"Max Super Specialty Hospital, Saket Delhi is a 500+ bedded premier hospital offering treatment across all medical disciplines such as Cardiology, Oncology, Neurosciences, Urology, Nephrology, all major organ transplants and other ancillary services. With 34+ lakh patients treated from 130 countries across 35 specialities, Max Super Specialty Hospital, Saket is a pioneer in Liver Transplant, Bone marrow transplant, Kidney Transplant, LVAD, HIPEC, Valvular Heart Surgery, and other critical surgeries. The hospital also has Asia’s Intraoperativr MRI neurological operation theatre, 1.5 Tesla MRI machine and a 64 Slice CT Angio. It has also been awarded various prestigious awards by AHPI - Association of Healthcare Providers of India."

During the past decade, Max Super Speciality Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Max Super Speciality Hospital" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Max Healthcare Insititute Limited" with 2 trials sponsored and "Stem Cell Therapeutics Corp." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Max Super Speciality Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Biocon Limited" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Max Super Speciality Hospital" are "Stroke" (3 trials), "Coronary Artery Disease" (2 trials), "Atherosclerosis" (1 trials), "Atrial Fibrillation" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Max Super Speciality Hospital" in a lesser frequency.

Most popular intervention types in "Max Super Speciality Hospital" are "Drug" (11 trials), "Device" (6 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Finerenone (BAY94-8862)" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Caspofungin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Max Super Speciality Hospital" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Max Super Speciality Hospital". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Max Super Speciality Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Max Super Speciality Hospital, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Max Super Speciality Hospital has several departments that took part in Clinical trials: "Max Super Speciality Hospital; Medical Oncology" - 3 trials